VPAC2 ( non-phospho ), VIP Receptor 2 Polyclonal Antibody

VPAC2 ( non-phospho ), VIP Receptor 2 Polyclonal Antibody

Catalog Number:
A001455968TMA
Mfr. No.:
7TM0372N
Price:
$528
  • Size:
    100 µl
    Quantity:
    Add to Cart:
      • Overview
        • The VPAC2 antibody is directed against the distal end of the carboxyl-terminal tail of mouse, rat and human VIP receptor 2. It can be used to detect total VPAC2 receptors in Western blots independent of phosphorylation. The VPAC2 antibody can also be used to isolate and enrich VPAC2 receptors from cell and tissue lysates. It also detects VPAC2 in cultured cells and tissue sections by immunohistochemistry.

          Please contact us at for specific academic pricing.

      • Properties
        • Host
          rabbit
          Antibody Type
          polyclonal
          Isotype
          IgG
          Reactivity
          human; mouse; rat
          Immunogen
          A synthetic peptide with sequence LQFHRGSRAQSFLQTETSVI corresponds to amino acids 419-438 of VPAC2.
          Purification
          Antigen affinity chromatography
          Formulation
          Liquid
          Storage
          Short-term storage at 4°C and long-term storage at -20°C
          Antigen
          VPAC2, VIP Receptor 2, Vasoactive Intestinal Peptide Receptor 2 (UniProt:P41587 (human), P41588 (mouse), P35000 (rat))

          * This product is intended for research use only.

      • Applications
        • Application
          WB; ICC; IHC
        • Application Dilutions
          Western Blot (WB) 1:1000
          Immunocytochemistry (ICC) 1:200
          Immunohistochemistry (IHC) 1:100
      • Reference
        • Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Clin Cancer Res. 2004 Dec 15;10(24):8235-42.
          Schulz S, Mann A, Novakhov B, Piggins HD, Lupp A. VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235. Endocr Connect. 2015 Mar;4(1):18-26. doi: 10.1530/EC-14-0051. Epub 2014 Dec 11. PubMed PMID: 25504760; PubMed Central PMCID: PMC4285768.

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.